Summer Sale
50% off Premium Yearly
Opinions Bruce Campbell (2)
Rocket Doctor AIAIDR-CSEBUYOct 22, 2025
Bruce Campbell (2)Stock price when the opinion was issued
You might be interested:
Doctors can use a "Shopify" model to market their "business" and get repeat patients, while accessing a global medical library that's been created with AI. Rolled out in Canada, now in some big US states, and being covered by US insurance. Expects it to be EBITDA-positive by year's end.
Bruce Campbell (2)Sort of a "Shopify" model for doctors. Lets a doctor see the same patients, compared to a Teladoc model when you never know who you're going to get. Allows doctors to specialize. Built-in medical library helps with diagnoses. Now ramping up from Canada to US, revenues should increase, and eventually will be EBITDA-positive.
AIDR is quite small at $75M market cap, after a 57% gain this year. It provides healthcare software solutions. Essentially, an AI doctor. But, currently it has minimal revenue, losses and negative cash flow. No analyst coverage. It does have some partnerships with insurance companies, with large numbers of members, so there is some potential here. But we need to see some sales in order to gauge what future profitability might be. There is competition in the space, certainly, as well. Insiders own 3%. While interesting, we would consider it too early here.
Unlock Premium - Try 5i Free
Uses AI with its global library of medicine that it custom-built over 8 years. Different from using ChatGPT, which looks everywhere trying to find an answer. They've run the program through the 12 patient scenarios given to med students, and it scored well enough to pass the exam.
Doctors like it because it helps with triage. Insurance companies like it because it cuts down costs. Has proven itself in Canada, and now going after the bigger market in the US -- starting to add the who's who of insurers such as UNH, Medicare, Medicaid, and HUM.
He wanted to use it as a Top Pick today, but it's just a bit too small of a market cap.